Oligodendrocyte Pathophysiology and Treatment Strategies in Cerebral Ischemia
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Summary: Oligodendrocytes (OL s), the myelin‐forming cells of the central nervous system, form a functional unit with axons and play a crucial role in axonal integrity. An episode of hypoxia–ischemia causes rapid and severe damage to these particularly vulnerable cells via multiple pathways such as overactivation of glutamate and ATP receptors, oxidative stress, and disruption of mitochondrial function. The cardinal effect of OL pathology is demyelination and dysmyelination, and this has profound effects on axonal function, transport, structure, metabolism, and survival. The OL is a primary target of ischemia in adult‐onset stroke and especially in periventricular leukomalacia and should be considered as a primary therapeutic target in these conditions. More emphasis is needed on therapeutic strategies that target OL s, myelin, and their receptors, as these have the potential to significantly attenuate white matter injury and to establish functional recovery of white matter after stroke. In this review, we will summarize recent progress on the role of OL s in white matter ischemic injury and the current and emerging principles that form the basis for protective strategies against OL death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · cited 2×
“Prolonged stimulation of P2X7 receptors also leads to several enzyme and secondary messenger cascades, with release of cytokines such as interleukin-1b and activation of mitogenactivated protein kinase (MAPK) and nuclear factor-jB, among others [75,81].”
BackgroundToxicity of iron and hydrogen peroxide: the Fenton reaction
Winterbourn, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03532-x · Cited by 1,415
The changing landscape of ischaemic brain injury mechanisms
Lee, J.-M., Zipfel, G. J., & Choi, D. W. (1999) · Nature · doi:10.1038/399a007 · Cited by 1,102 · cited 1×
“Glutamate excitotoxicity is one of the major contributors toward ischemic injury in the CNS [50].”
BackgroundTNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · cited 10×
“Introduction After an episode of cerebral hypoxia–ischemia (HI), early events include energy crisis, cell depolarization from the breakdown of transmembrane gradients, cytotoxic edema, reactive oxygen species (ROS) production, and endothelial dysfunction [1].”
BackgroundInfluentialNMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Selective Vulnerability of Late Oligodendrocyte Progenitors to Hypoxia–Ischemia
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., Arvin, K. L., & Holtzman, D. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00455.2002 · Cited by 795 · cited 11×
“We now know that OLs are major targets of cerebral ischemia, both in the case of adult-onset stroke and especially in PVL, which means that treatment strategies that exclusively target neuronal recovery cannot be optimally successful.”
BackgroundInfluentialEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · cited 1×
“Axons that have been demyelinated as a result of trauma or disease can be remyelinated by immature cells that “respond to demyelination by differentiating into myelinating OLs” [105].”
BackgroundStevens (2002) · doi:10.1016/s0896-6273(02)01067-x · Cited by 543
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399 · cited 1×
“Once in the cytosol, the cystine is converted to cysteine, which is used in the production of glutathione [71].”
Background
Cited by
Glial Cells: Role of the Immune Response in Ischemic Stroke
Xu, S., Lu, J., Shao, A., Zhang, J. H., & Zhang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00294 · Cited by 601
Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells
Belov Kirdajova, D., Kriska, J., Tureckova, J., & Anderova, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00051 · Cited by 428
White matter injury in ischemic stroke
Wang, Y., Liu, G., Hong, D., Chen, F., Ji, X., & Cao, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.005 · Cited by 309
Hypoxia after stroke: a review of experimental and clinical evidence
Ferdinand, P., & Roffe, C. (2016) · Experimental & Translational Stroke Medicine · doi:10.1186/s13231-016-0023-0 · Cited by 119
Liu, L., Liu, X., Zhao, J., Yan, F., Wang, R., Wen, S., Wang, L., Luo, Y., & Ji, X. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13061 · Cited by 44
Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD
Jiang, G., Ayaki, T., Maki, T., Yasuda, K., Yoshii, D., Kaji, S., & Takahashi, R. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137405 · Cited by 11
Metadata
- Authors
- Mifsud, G., Zammit, C., Muscat, R., Di Giovanni, G., & Valentino, M.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2014-04-07
- Volume
- 20
- Issue
- 7
- Pages
- 603-612
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2151276541
- Cited by
- 118
- References
- 17
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.